Vericiguat reduces atrial fibrillation recurrence by alleviating myocardial fibrosis via the TGF-β1/Smad2/3 pathway - Xiaolin Sun; Yawen Sheng; Pei Xu; Qian Peng; Zhongbao Ruan (PLoS ONE, 2025)